8.3
C
Manchester
Trending now
The 360 Dental Practice Success Conference 2026…
Austin Buyers Agents – Sydney’s Premier Buyers…
McDonald’s is about to report earnings. Here’s…
Seoul launches garden-themed merchandise tied to 2026…
S. Korea’s 1st US investment under trade…
Warner Bros. Discovery books $2.9 billion net…
FanDuel CEO Amy Howe is out after…
Apollo CEO Rowan warns of market correction,…
Valetax Enhances Leadership Team with Appointment of…
From Innovation to Global Scale: Podim 2026…
Home
News
Business
National
Press Release
Finanace
Search for:
Search
Primary Menu
Search for:
Search
Home
Business
FDA vaccine head will step down in April after string of controversial decisions
Business
FDA vaccine head will step down in April after string of controversial decisions
by
Douglas L. Grider
Vinay Prasad is leaving his post as director of the Center for Biologics Evaluation and Research.
previous post
FDA reversals leave investors worrying about the fates of other experimental drugs
next post
[TEST DRIVE] Renault Korea’s Filante set to take on Santa Fe, Sorento
Douglas L. Grider
Related posts
JPMorgan Chase tops estimates as trading revenue exceeds expectations
Douglas L. Grider
January 13, 2026
Lucid names auto industry outsider as CEO, expands Uber deal
Douglas L. Grider
April 14, 2026
Nexstar, Tegna merger closes after winning regulatory approval
Douglas L. Grider
March 20, 2026